World-first saliva technology could replace painful spinal taps and costly PET scans, offering early diagnosis of major brain disorders through a simple, low-cost test. Serious brain illnesses such as Parkinson's disease, schizophrenia, and epilepsy have traditionally been diagnosed with expensive PET brain scans or invasive spinal taps that involve collecting fluid from the spine. South Korean researchers have devised a highly accurate saliva-based test that might make early detection as simple as submitting a little sample of spit. 

Dr Sung-Gyu Park of the Korea Institute of Materials Science's Advanced Bio and Healthcare Materials Research Division led the study, which was conducted in collaboration with Prof. Ho Sang Jung of Korea University and clinical researchers from the College of Medicine at The Catholic University of Korea. Their findings were published in Advanced Materials, a top global publication in materials science, and received international attention. 

The researchers developed the Galvanic Molecular Entrapment-Surface Enhanced Raman Scattering platform, or GME-SERS. Simply put, instead of measuring the amount of a protein in the body, the technology examines the structure of proteins detected in saliva. Many brain illnesses are caused by improper protein folding. They twist, misfold, and clump together to form dangerous formations. These aberrant structures, known as fibrils, are connected to nerve cell injury. 

The new device catches these proteins using small nanostructures comprised of gold and copper oxide. When this occurs, special "hotspots" emerge, amplifying fragile light signals from the proteins by over a billion times. The result enables clinicians to detect minute structural changes that were previously impossible to measure. In effect, the sensor works as a powerful molecular magnifying glass. 
Also Read: Scientists Use Ear Wax to Detect Parkinson’s Early

To test the method, researchers examined saliva samples from 44 people with epilepsy, schizophrenia, and Parkinson's disease, as well as 23 healthy individuals. The results indicated that the test could discriminate patients from healthy controls with an accuracy rate greater than 90% and as high as 98% in some circumstances. 

Dr Sung-Gyu Park stated, "A new era has dawned in which brain illness disorders can be assessed using simple saliva analysis instead of expensive PET imaging or cerebrospinal fluid tests. Because the work was published in a top-tier international magazine, the technology's originality and creativity are now officially recognised around the world." 

Prof. Ho Sang Jung continued: "Given its non-invasive and low-cost nature, the technology holds significant potential for expansion beyond hospital outpatient settings to include home-based diagnostic devices." 

Experts believe that early diagnosis is crucial in neurological illnesses. Parkinson's disease, for example, frequently manifests noticeable symptoms only after considerable brain damage has occurred. Schizophrenia and epilepsy both benefit from early detection and treatment. A simple screening technique could shorten diagnostic delays, particularly in low-resource areas where advanced brain imaging is not readily available. 

The research team is now attempting to commercialise the breakthrough by creating portable, point-of-care diagnostic devices using Raman sensor technology. These might work similarly to glucose monitors or pregnancy tests, bringing advanced neurological screening into clinics—and possibly even homes. 

If validated in larger clinical trials, the saliva test has the potential to revolutionise brain health diagnostics by minimising physical discomfort, lowering medical expenses, and providing millions of patients with a faster, safer path to early identification.